close
close

Experts in 12p tablets say it could reverse and prevent diabetes

Health experts have singled out a particular herb that could help reverse or prevent diabetes.

Research has shown that fenugreek can have a positive impact on blood sugar and cholesterol levels. Fenugreek is available in pill form from health food stores such as Holland and Barrett. A tub of 90 capsules costs £10.99, working out to just 12p per tablet.




The leaves and seeds of fenugreek plants are versatile and can be used in a variety of ways. They add a unique flavor to curries and other dishes, making them a staple ingredient in many Asian recipes. Fenugreek is also recognized for its medicinal properties.

Fenugreek seeds, also known as trigonella foenum graecum, are rich in soluble fiber. This type of fiber helps lower blood sugar levels by slowing the digestion and absorption of carbohydrates, reports Wales Online.

What does the research say?

Fenugreek seeds are small and brown in color

Numerous studies have indicated potential antidiabetic benefits of fenugreek. Several clinical studies have shown that fenugreek seeds can alleviate various metabolic problems associated with type 1 and type 2 diabetes, including lowering blood sugar levels and improving glucose tolerance.

Research in India has shown that adding 100 grams of defatted fenugreek seed powder to the daily diet of people with type 1 diabetes can significantly reduce fasting blood sugar levels. It also improved glucose tolerance and lowered total cholesterol, LDL cholesterol, and triglycerides.

In another study, people with type 2 diabetes who consumed 15 grams of powdered fenugreek seeds with a meal experienced less of a rise in blood sugar levels after the meal. Further research indicated that taking 2.5 grams of fenugreek twice a day for three months might benefit those with mild type 2 diabetes by lowering blood sugar levels, although it had no effect on severe cases.

A 2015 study further confirmed the benefits of fenugreek seeds in managing blood glucose levels in diabetic patients. Over a three-year period, men and women aged 30 to 70 with prediabetes were divided into two groups.

Related Articles

Back to top button